Jeong-Ju Yoo, Won Kim, Moon Young Kim, Dae Won Jun, Sang Gyune Kim, Jong-Eun Yeon, Jin Woo Lee, Yong Kyun Cho, Sang Hoon Park, Joo Hyun Sohn, On behalf of the Korean Association for the Study of the Liver (KASL)-Korea Nonalcoholic fatty liver Study Group (KNSG)
Clin Mol Hepatol 2019;25(1):1-11. Published online August 8, 2018
Nonalcoholic fatty liver disease (NAFLD), together with metabolic syndrome and obesity, has shown a rapid increase in prevalence worldwide and is emerging as a major cause of chronic liver disease and liver transplantation. Among the various phenotypes of NAFLD, nonalcoholic steatohepatitis (NASH) is highly likely to progress to development of end-stage liver disease and cardiometabolic disease, resulting in liver-related and non-liver–related mortality. Nonetheless, there is no standardized pharmacotherapy against NASH and many drugs are under development in ongoing clinical trials. To develop a successful anti-NASH drug, it is necessary to select an appropriate target population and treatment outcomes depending on whether the mode of action is anti-metabolic, anti-inflammatory or anti-fibrotic. Recently, innovative surrogate markers have been investigated to replace hard outcomes such as liver histology and mortality and reduce the clinical trial duration. Currently, several drugs with fast track designation are being tested in phase III clinical trials, and many other drugs have moved into phase II clinical trials. Both lean NAFLD and typical obese NAFLD have been extensively studied and genetic variants such as PNPLA3 and TM6SF2 have been identified as significant risk factors for lean NAFLD. In the near future, noninvasive biomarkers and effective targeted therapies for NASH and associated fibrosis are required to develop precision medicine and tailored therapy according to various phenotypes of NAFLD.
Citations
Citations to this article as recorded by
A Literature Review of Glutathione Therapy in Ameliorating Hepatic Dysfunction in Non-Alcoholic Fatty Liver Disease Michelle Thuy Nguyen, Andrew Lian, Frederick Timothy Guilford, Vishwanath Venketaraman Biomedicines.2025; 13(3): 644. CrossRef
Impact of sleeve gastrectomy on the course of metabolic associated fatty liver disease Ragaey Ahmad Eid, Dina Attia, Asmaa Srour Soliman, Eman Ahmed Abd Elmaogod, Eman Mohammed AbdelSalam, Ahmed Mohamed Rashad, Ahmed Safaa Ahmed Sayed, Tamer Mohamed Nabil Indian Journal of Gastroenterology.2025;[Epub] CrossRef
Reply to correspondence 1 on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers” Yoon-su Ha, Won Kim, Seung-Jin Kim Clinical and Molecular Hepatology.2025; 31(2): e226. CrossRef
Correspondence to editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers” Yi-Tong Li, Wei-Qing Shao, Zhen-Mei Chen, Jing Lin, Jin-Hong Chen Clinical and Molecular Hepatology.2025; 31(2): e186. CrossRef
Impact of the FIB4 Index on Pre-sarcopenia in Patients with Metabolic-dysfunction Associated Steatotic Liver Disease Hiroki Nishikawa, Tomohiro Nishikawa, Akira Fukuda, Kosuke Ushiro, Masahiro Matsui, Saori Onishi, Soo Ki Kim, Akira Asai Internal Medicine.2025; 64(21): 3078. CrossRef
Clinical characteristics of lean and non-lean non-alcoholic fatty liver disease: a cross-sectional study Mengyan Xu, Rui Gong, Jiao Xie, Sanping Xu, Shi Wang Nutrition & Metabolism.2025;[Epub] CrossRef
Liver involvement in Gaucher disease in children: A literature review and clinical observations G.V. Volynets, G.B. Movsisyan, A.S. Potapov, A.I. Khavkin, A.V. Nikitin, T.A. Skvortsova, E.A. Morozova, V.M. Rogozhina Russian Journal of Evidence-Based Gastroenterology.2025; 14(2): 78. CrossRef
PNPLA3-Ile148Met and TM6SF2-Glu167Lys increase susceptibility to metabolic dysfunction-associated steatotic liver disease in children Hengpan Yao, Zhiyi Xia, Yijing Liu, MengJun Dong, Kairui Yang, Fang Zhou Frontiers in Endocrinology.2025;[Epub] CrossRef
Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities,
and Management of Non-alcoholic Fatty Liver Disorder Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin Current Drug Therapy.2024; 19(1): 20. CrossRef
Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases Arianna Ferro, Gabriele Saccu, Simone Mattivi, Andrea Gaido, Maria Beatriz Herrera Sanchez, Shafiul Haque, Lorenzo Silengo, Fiorella Altruda, Marilena Durazzo, Sharmila Fagoonee Biomolecules.2024; 14(3): 277. CrossRef
Three-Step Algorithm for Screening High-Risk Group of Metabolic Dysfunction-Associated Steatotic Liver Disease in General Population Joo Hyun Oh, Dae Won Jun Gut and Liver.2024; 18(2): 197. CrossRef
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers Francesca Terracciani, Andrea Falcomatà, Paolo Gallo, Antonio Picardi, Umberto Vespasiani-Gentilucci Journal of Physiology and Biochemistry.2023; 79(4): 851. CrossRef
Impact of thyroid cancer on the cancer risk in patients with non-alcoholic fatty liver disease or dyslipidemia Joon Ho, Eunhwa Kim, Myeongjee Lee, Inkyung Jung, Young Suk Jo, Jandee Lee Scientific Reports.2023;[Epub] CrossRef
Global incidence and prevalence of nonalcoholic fatty liver disease Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D. Muthiah Clinical and Molecular Hepatology.2023; 29(Suppl): S32. CrossRef
Associations between Adipokines and Metabolic Dysfunction-Associated Fatty Liver Disease Using Three Different Diagnostic Criteria Jie Pan, Yijie Ding, Yan Sun, Qiuyan Li, Tianyi Wei, Yingying Gu, Yujia Zhou, Nengzhi Pang, Lei Pei, Sixi Ma, Mengqi Gao, Ying Xiao, De Hu, Feilong Wu, Lili Yang Journal of Clinical Medicine.2023; 12(6): 2126. CrossRef
Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments Sang Bong Ahn Clinical and Molecular Hepatology.2023; 29(Suppl): S150. CrossRef
Non-Traditional Blood Lipid Indices for Metabolism Dysfunction-Associated Fatty Liver Disease Prediction in Non-Obese Type 2 Diabetes Mellitus Qian Gao, Lei Feng, Weiling Zhou, Xiaoli Li, Lanzi Yin, Yuan Wang Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 2345. CrossRef
Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive review Mah I Kan Changez, Maryam Mubeen, Monezahe Zehra, Inara Samnani, Aniqa Abdul Rasool, Anmol Mohan, Um Ul Wara, Usha Tejwaney, Vikash Kumar Journal of International Medical Research.2023;[Epub] CrossRef
Association between PNPLA3 and TM6SF2 gene polymorphisms and non-alcoholic fatty liver disease patients in Kazakhstan Ainura Amirkulova, Gulmira Derbissalina, Valeriy Benberin, Nasrulla Shanazarov, Gulshara Abildinova, Doskhan Kozhakhmet, Helena Katchman Electronic Journal of General Medicine.2023; 20(6): em546. CrossRef
The empirical dietary inflammatory pattern score and the risk of nonalcoholic fatty liver disease and cirrhosis Maryam K. Ibrahim, Robert M. Wilechansky, Prasanna K. Challa, Xuehong Zhang, Edward Giovannucci, Meir Stampfer, Andrew T. Chan, Tracey G. Simon Hepatology Communications.2023;[Epub] CrossRef
Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease Apostolis PAPAEFTHYMIOU, Michael DOULBERIS, Kyriaki KARAFYLLIDOU, Eleftherios CHATZIMICHAEL, Georgia DERETZI, Aristomenis K. EXADAKTYLOS, Fotios SAMPSONAS, Athanasios GELASAKIS, Spyros I. PAPAMICHOS, Georgios KOTRONIS, Dimitra GIALAMPRINOU, Elisabeth VARD Minerva Endocrinology.2023;[Epub] CrossRef
The experience of the "Nicolae Malaxa" Clinical Hospital Bucharest, 2021-2022: non-alcoholic hepatic steatosis – etiological and risk profile Gabriela-Carmen Obilişteanu, Alexandru-Mihai Ştefănescu, Florin-Mihai Lungana, Nicolae Runcanu Medic.ro.2023; 5(155): 8. CrossRef
Molecular Docking Study of Phytosterols in Lygodium microphyllum Towards SIRT1 and AMPK, the in vitro Brine Shrimp Toxicity Test, and the Phenols and Sterols Levels in the Extract Putri Anggreini, Hadi Kuncoro, Sri Sumiwi, Jutti Levita Journal of Experimental Pharmacology.2023; Volume 15: 513. CrossRef
Both full length‐cholesteryl ester transfer protein and exon 9‐deleted cholesteryl ester transfer protein promote triacylglycerol storage in cultured hepatocytes Yan Liu, Daniel Mihna, Lahoucine Izem, Richard E. Morton Lipids.2022; 57(1): 69. CrossRef
Red meat consumption, obesity, and the risk of nonalcoholic fatty liver disease among women: Evidence from mediation analysis Mi Na Kim, Chun-Han Lo, Kathleen E. Corey, Xiao Luo, Lu Long, Xuehong Zhang, Andrew T. Chan, Tracey G. Simon Clinical Nutrition.2022; 41(2): 356. CrossRef
Advanced liver fibrosis measured by transient elastography predicts chronic kidney disease development in individuals with non-alcoholic fatty liver disease Chan-Young Jung, Geun Woo Ryu, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim Diabetologia.2022; 65(3): 518. CrossRef
Long-term surgical outcomes of Non alcoholic fatty liver disease associated hepatocellular carcinoma Mizelle D'Silva, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Moonhwan Kim Surgical Oncology.2022; 41: 101730. CrossRef
MRE-based NASH score for diagnosis of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease Young-Sun Lee, Ji Eun Lee, Hyon-Seung Yi, Young Kul Jung, Dae Won Jun, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Baek-hui Kim, Jeong Woo Kim, Chang Hee Lee, Jong Eun Yeon, Juneyoung Lee, Soon Ho Um, Kwan Soo Byun Hepatology International.2022; 16(2): 316. CrossRef
DNA Methylation Patterns According to Fatty Liver Index and Longitudinal Changes from the Korean Genome and Epidemiology Study (KoGES) Young Kyung Ko, Hayeon Kim, Yoonseok Lee, Young-Sun Lee, Jeong-An Gim Current Issues in Molecular Biology.2022; 44(3): 1149. CrossRef
Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease Yuna Kim, Eugene Han, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Mi Kyung Kim, Hye Soon Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Yong-ho Lee, Seung Up Kim Gut and Liver.2022; 16(2): 290. CrossRef
Exercise reduces the risk of chronic kidney disease in individuals with nonalcoholic fatty liver disease: A nationwide cohort study Chan-Young Jung, Ho Soo Chun, Minjong Lee, Hee Byung Koh, Keun Hyung Park, Young Su Joo, Hyung Woo Kim, Sang Hoon Ahn, Jung Tak Park, Seung Up Kim Diabetes & Metabolism.2022; 48(5): 101362. CrossRef
Tenofovir alafenamide alleviates nonalcoholic steatohepatitis in mice by blocking the phosphorylation of AKT in intrahepatic mononuclear phagocytes Pu Reun Roh, Sung Min Kim, Byung-Yoon Kang, Kyoung Do Mun, Jong Geun Park, Min Woo Kang, Wonhee Hur, Ji Won Han, Heechul Nam, Seung Kew Yoon, Pil Soo Sung Biomedicine & Pharmacotherapy.2022; 156: 113952. CrossRef
Environmental exposure to organophosphate esters and suspected non-alcoholic fatty liver disease among US adults: A mixture analysis Haisheng Chai, Weiye Hu, Yaoyao Dai, Xiaohan Zhu, Ping'an Qian, Junfeng Zhu Frontiers in Public Health.2022;[Epub] CrossRef
A Nomogram Based on Preoperative Lab Tests, BMI, ICG-R15, and EHBF for the Prediction of Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma Deyao Zhang, Yangxun Pan, Zhenyun Yang, Huilan Zeng, Xin Wang, Jinbin Chen, Juncheng Wang, Yaojun Zhang, Zhongguo Zhou, Minshan Chen, Dandan Hu Journal of Clinical Medicine.2022; 12(1): 324. CrossRef
Association between depression and nonalcoholic fatty liver disease: Contributions of insulin resistance and inflammation Ju Won Lee, Seung Ha Park Journal of Affective Disorders.2021; 278: 259. CrossRef
Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years Hye Won Lee, Jae Seung Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim Journal of Diabetes and its Complications.2021; 35(1): 107747. CrossRef
Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective Gwyneth Soon, Aileen Wee Clinical and Molecular Hepatology.2021; 27(1): 44. CrossRef
Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes Ho Soo Chun, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yong‐Ho Lee, Young Dae Kim, Seung Up Kim Journal of Gastroenterology and Hepatology.2021; 36(6): 1703. CrossRef
From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple? Seong Hee Kang, Yuri Cho, Soung Won Jeong, Seung Up Kim, Jin-Woo Lee Clinical and Molecular Hepatology.2021; 27(2): 257. CrossRef
Body weight variability and the risk of cardiovascular outcomes in patients with nonalcoholic fatty liver disease Mi Na Kim, Kyungdo Han, Juhwan Yoo, Yeonjung Ha, Young Eun Chon, Ju Ho Lee, Tracey G. Simon, Andrew T. Chan, Seong Gyu Hwang Scientific Reports.2021;[Epub] CrossRef
Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy Jin Won Chang, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim Gut and Liver.2021; 15(1): 117. CrossRef
Clinical implications of renin–angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease Kwang Min Kim, Ji-Hye Roh, Sangjin Lee, Jeong-Hyun Yoon Scientific Reports.2021;[Epub] CrossRef
Nonalcoholic Fatty Liver Disease: A Global Perspective Wei-Kei Wong, Wah-Kheong Chan Clinical Therapeutics.2021; 43(3): 473. CrossRef
Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver Min-Kyu Kang, Jung-Hun Baek, Young-Oh Kweon, Won-Young Tak, Se-Young Jang, Yu-Rim Lee, Keun Hur, Gyeonghwa Kim, Hye-Won Lee, Man-Hoon Han, Joon-Hyuk Choi, Soo-Young Park, Jung-Gil Park Diagnostics.2021; 11(6): 1061. CrossRef
Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease Tae Hyung Kim, Yoonseok Lee, Young-Sun Lee, Jeong-An Gim, Eunjung Ko, Sun Young Yim, Young Kul Jung, SeongHee Kang, Moon Young Kim, Hayeon Kim, Baek-hui Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun Scientific Reports.2021;[Epub] CrossRef
Inhaled exposure to air fresheners aggravated liver injury in a murine model of nonalcoholic fatty acid liver disease Sanghwa Kim, Ah Young Lee, Myung-Haing Cho Heliyon.2021; 7(3): e06452. CrossRef
Low Skeletal Muscle Mass Is a Risk Factor for Subclinical Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease Min-Kyu Kang, Jung-Gil Park Diagnostics.2021; 11(5): 854. CrossRef
Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease Hee Kyung Shin, Jeong Hwan Park, Jung Hwan Yu, Young-Joo Jin, Young Ju Suh, Jin-Woo Lee, Won Kim Scientific Reports.2021;[Epub] CrossRef
Metabolic disease as a risk of hepatocellular carcinoma Naoshi Nishida Clinical and Molecular Hepatology.2021; 27(1): 87. CrossRef
Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expression Jeong-An Gim, Soo Min Bang, Young-Sun Lee, Yoonseok Lee, Sun Young Yim, Young Kul Jung, Hayeon Kim, Baek-Hui Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun, Matias A. Avila PLOS ONE.2021; 16(8): e0255822. CrossRef
Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non‐alcoholic fatty liver disease Jung Gil Park, Jinho Jung, Kritin K. Verma, Min Kyu Kang, Egbert Madamba, Scarlett Lopez, Aed Qas Yonan, Amy Liu, Ricki Bettencourt, Claude Sirlin, Rohit Loomba Alimentary Pharmacology & Therapeutics.2021; 53(9): 1030. CrossRef
Systematic review with meta‐analysis: bariatric surgery reduces the incidence of hepatocellular carcinoma Daryl Ramai, Jameel Singh, Janice Lester, Shahab R. Khan, Saurabh Chandan, Nicola Tartaglia, Antonio Ambrosi, Gaetano Serviddio, Antonio Facciorusso Alimentary Pharmacology & Therapeutics.2021; 53(9): 977. CrossRef
Lack of association between early menopause and non-alcoholic fatty liver disease in postmenopausal women S. H. Park, Y. E. Park, J. Lee, J. H. Choi, N. Y. Heo, J. Park, T. O. Kim, Y. S. Moon, H. K. Kim, H. J. Jang, H. Y. Park, C.-H. Jeong, K. T. Suk, D. J. Kim Climacteric.2020; 23(2): 173. CrossRef
Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017 Seung Ha Park, Lindsay D. Plank, Ki Tae Suk, Yong Eun Park, Jin Lee, Joon Hyuk Choi, Nae Yun Heo, Jongha Park, Tae Oh Kim, Young Soo Moon, Hyun Kuk Kim, Hang Jea Jang, Ha Young Park, Dong Joon Kim Clinical and Molecular Hepatology.2020; 26(2): 209. CrossRef
Liver involvement in patients with Gaucher disease types I and III Rodrigo Tzovenos Starosta, Filippo Pinto e Vairo, Alícia Dorneles Dornelles, Suélen Porto Basgalupp, Marina Siebert, Maria Lúcia Alves Pedroso, Carlos Thadeu Schmidt Cerski, Mário Reis Álvares-da-Silva, Ida Vanessa Doederlein Schwartz Molecular Genetics and Metabolism Reports.2020; 22: 100564. CrossRef
Association of grip strength with non-alcoholic fatty liver disease: investigation of the roles of insulin resistance and inflammation as mediators Seung Ha Park, Dong Joon Kim, Lindsay D. Plank European Journal of Clinical Nutrition.2020; 74(10): 1401. CrossRef
Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017 Mi Jin Kim, Kyung Jae Lee BMC Pediatrics.2020;[Epub] CrossRef
Multiparametric MR Is a Valuable Modality for Evaluating Disease Severity of Nonalcoholic Fatty Liver Disease Young-Sun Lee, Yang Jae Yoo, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, In Hee Kim, Soo Yeon Lee, Baek-Hui Kim, Jeong Woo Kim, Chang Hee Lee, Jong Eun Yeon, So Young Kwon, Soon Ho Um, Kwan Soo Byun Clinical and Translational Gastroenterology.2020; 11(4): e00157. CrossRef
Toll-like receptor 9, a possible blocker of non-alcoholic steatohepatitis? Soung Won Jeong Clinical and Molecular Hepatology.2020; 26(2): 185. CrossRef
Does limited expression of toll-like receptor 9 actually contribute to T cell activation and liver damage in nonalcoholic steatohepatitis? Hyuk Soo Eun Clinical and Molecular Hepatology.2020; 26(2): 236. CrossRef
Survival Outcomes According to Body Mass Index in Hepatocellular Carcinoma Patient: Analysis of Nationwide Cancer Registry Database Boram Cha, Jung Hwan Yu, Young-Joo Jin, Young Ju Suh, Jin-Woo Lee Scientific Reports.2020;[Epub] CrossRef
Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease Seon Young Ahn, Suk Bae Kim, Il Han Song Canadian Journal of Gastroenterology and Hepatology.2020; 2020: 1. CrossRef
Clinical application of ultrasonography-guided percutaneous liver biopsy and its safety over 18 years Young Chang, Jun Il Kim, Bora Lee, Sang Gyune Kim, Min Jung Jung, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Jeong-Ju Yoo Clinical and Molecular Hepatology.2020; 26(3): 318. CrossRef
Effects of a 6-month dietary-induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The Fatty Liver in Obesity study Bertha Araceli Marin-Alejandre, Itziar Abete, J. Ignacio Monreal, Mariana Elorz, Alberto Benito-Boillos, José Ignacio Herrero, Iñigo Navarro-Blasco, Josep A. Tur, Narcisa M. Bandarra, M. Angeles Zulet, J. Alfredo Martinez Journal of Clinical Lipidology.2020; 14(6): 837. CrossRef
Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease Min Kyu Kang, Jung Gil Park, Min Cheol Kim Yonsei Medical Journal.2020; 61(10): 860. CrossRef
Plasma Long Noncoding RNA LeXis is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis Jung Gil Park, Gyeonghwa Kim, Se Young Jang, Yu Rim Lee, Eunhye Lee, Hye Won Lee, Man-Hoon Han, Jae Min Chun, Young Seok Han, Jun Sik Yoon, Min Kyu Kang, Young Oh Kweon, Won Young Tak, Soo Young Park, Keun Hur Life.2020; 10(10): 230. CrossRef
Weight gain during early adulthood, trajectory of body shape and the risk of nonalcoholic fatty liver disease: A prospective cohort study among women Mi Na Kim, Chun-Han Lo, Kathleen E. Corey, Po-Hong Liu, Wenjie Ma, Xuehong Zhang, Manol Jovani, Mingyang Song, Andrew T. Chan, Tracey G. Simon Metabolism.2020; 113: 154398. CrossRef
Nonalcoholic Fatty Liver Disease: A Drug Revolution Is Coming Soung Won Jeong Diabetes & Metabolism Journal.2020; 44(5): 640. CrossRef
Sarcopenia Is a New Risk Factor of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease Min Kyu Kang, Kyeong Ok Kim, Min Cheol Kim, Jung Gil Park, Byung Ik Jang Digestive Diseases.2020; 38(6): 507. CrossRef
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros Metabolism.2019; 92: 82. CrossRef
Advancing the understanding of NAFLD to hepatocellular carcinoma development: From experimental models to humans Kan Chen, Jianbo Ma, Xiaoyuan Jia, Wen Ai, Zhongren Ma, Qiuwei Pan Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2019; 1871(1): 117. CrossRef
Editorial: effect of hepatic steatosis on liver stiffness in patients with chronic hepatitis B Beom Kyung Kim, Seung Up Kim Alimentary Pharmacology & Therapeutics.2019; 50(3): 333. CrossRef
Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study Beom Kyung Kim, Do Young Kim, Kwang-Hyub Han, Jinsil Seong, Jung Weon Lee PLOS ONE.2019; 14(10): e0223678. CrossRef
The evaluation of complications and mortality in non-alcoholic steatohepatitis-related cirrhosis Sezgin VATANSEVER, Zehra Betül PAKÖZ Marmara Medical Journal.2019; 32(1): 44. CrossRef
First
Prev
